Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,895 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hand, foot, and mouth disease caused by coxsackievirus A6, Japan, 2011.
Fujimoto T, Iizuka S, Enomoto M, Abe K, Yamashita K, Hanaoka N, Okabe N, Yoshida H, Yasui Y, Kobayashi M, Fujii Y, Tanaka H, Yamamoto M, Shimizu H. Fujimoto T, et al. Among authors: abe k. Emerg Infect Dis. 2012 Feb;18(2):337-9. doi: 10.3201/eid1802.111147. Emerg Infect Dis. 2012. PMID: 22304983 Free PMC article. No abstract available.
Oseltamivir-resistant influenza viruses A (H1N1) during 2007-2009 influenza seasons, Japan.
Ujike M, Shimabukuro K, Mochizuki K, Obuchi M, Kageyama T, Shirakura M, Kishida N, Yamashita K, Horikawa H, Kato Y, Fujita N, Tashiro M, Odagiri T; Working Group for Influenza Virus Surveillance in Japan. Ujike M, et al. Emerg Infect Dis. 2010 Jun;16(6):926-35. doi: 10.3201/eid1606.091623. Emerg Infect Dis. 2010. PMID: 20507742 Free PMC article.
Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus, Japan, 2009-2010.
Ujike M, Ejima M, Anraku A, Shimabukuro K, Obuchi M, Kishida N, Hong X, Takashita E, Fujisaki S, Yamashita K, Horikawa H, Kato Y, Oguchi A, Fujita N, Tashiro M, Odagiri T; Influenza Virus Surveillance Group of Japan. Ujike M, et al. Emerg Infect Dis. 2011 Mar;17(3):470-9. doi: 10.3201/eid1703.101188. Emerg Infect Dis. 2011. PMID: 21392439 Free PMC article.
Switching from Beraprost to Selexipag in the Treatment of Pulmonary Arterial Hypertension: Insights from a Phase IV Study of the Japanese Registry (The EXCEL Study: EXChange from bEraprost to seLexipag Study).
Tamura Y, Kumamaru H, Tsujino I, Suda R, Abe K, Inami T, Horimoto K, Adachi S, Yasuda S, Sera F, Taniguchi Y, Kuwana M, Tatsumi K; Japan Pulmonary Hypertension Registry Network. Tamura Y, et al. Among authors: abe k. Pharmaceuticals (Basel). 2024 Apr 26;17(5):555. doi: 10.3390/ph17050555. Pharmaceuticals (Basel). 2024. PMID: 38794126
Simple prediction tools for disease progression in unvaccinated patients with mild/moderate COVID-19 aged under 65 years: Simplified DOATS and DOAT scores.
Shibata Y, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Rikimaru M, Kawamata T, Togawa R, Sato Y, Saito J, Kanazawa K, Iseki K; Doctors in Fukushima and Yamagata against COVID-19. Shibata Y, et al. Respir Investig. 2024 May 22;62(4):681-684. doi: 10.1016/j.resinv.2024.05.006. Online ahead of print. Respir Investig. 2024. PMID: 38781788
6,895 results